eSUNMed is committed to the development of biomedical materials.
The main business of eSUNMed includes biomedical monomers (caprolactone CL, etc.), biomedical polymers (L-polylactic acid PLLA, etc.),
Medical 3D printing materials (implantation grade peek, etc.) and medical processing services (polycaprolactone microspheres PCL, etc.). Please feel free to inquire!

about
eSUNMed

eSUNMed experts in the field of biomedical materials, integrating R&D, production and sales. eSUNMed is located in Longhua District, Shenzhen. The main base covers an area of more than 2,000 square meters. It has a 100,000-level clean workshop and a 10,000-level purification laboratory.

eSUNMed has developed the industrialization technology of polylactic acid and polycaprolactone and has complete process experience in the industrialization of esters. eSUNMed’s products include biomedical monomers (caprolactone CL, lactide LA), biomedical polymers (L-polylactic acid PLLA, D-polylactide PDLA, etc.), medical 3D printing materials (implantable peek, pla, etc.) and medical processing services (polycaprolactone microspheres PCL, polylactic acid microspheres PLA, etc.).

news and information

news_img

From Biodegradable Polyester Powder to Bone Repair Scaffolds: SLS 3D Printing Empowering Precision Medicine

Background In recent years, biodegradable polymers and additive manufacturing technologies have attracted significant attention in the field of bone tissue engineering. Polylactic acid (PLA) and its copolymers, as thermoplastic polymers with good biocompatibility and safe degradation products, ha...

View Details
news_img

Stimulative Regenerative Aesthetic Fillers: Biodegradable Polyester Materials Empowering Innovative Development

Dr. Shidao Kun, Director of Biotechnology at eSUNMed, was invited to attend the T20+ Conference, where he delivered a keynote speech titled “Innovative Breakthroughs and Future Prospects of Biodegradable Polyester Materials in the High-End Aesthetic Field.” In his presentation, he shared cutting-...

View Details
news_img

eSUNMed’s PLGA Raw Material Successfully Registered, Empowering the Biomedical Industry Upgrade

On July 11, 2025, eSUNMed successfully completed the master file registration of its independently developed medical-grade PLGA raw material with the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA). The registration number is (M2025250-000). This milestone ...

View Details
news_img

Biomedical Applications and Recycling of eSUNMEd Biodegradable Polyester Materials

From June 20 to 22, the Chinese Academy of Engineering’s Science and Technology Symposium—Polymer Recycling and Sustainable Development and the 8th Polymer Recycling and Upcycling Symposium—was successfully held in Chengdu. At the thematic session on “Bio-based and Biodegradable Polymer Mat...

View Details
news_img

“Molding” New Bones: Biodegradable Polyesters Empower Bone Regeneration

Each year, approximately 2.2 million bone graft surgeries are performed globally, yet the repair of large-volume bone defects remains a significant clinical challenge. Currently, bone repair materials are mainly categorized into three types: autologous bone, natural bone grafts, and synthetic b...

View Details